amorphous
Ensuring Stability the Biggest Amorphous Challenge for 88.2% of Developers
July 27 by Pharma IQThe use of amorphous pharmaceutical materials is widely considered an effective way of improving favourable drug properties and the latest findings from Pharma IQ suggest that many developers consider...
The Rise of Academic/Industry Collaboration in Amorphous Material Studies
May 30 by Helen WinsorMarc Descamps, Professor in Solid State Physics at Université Lille and Lead of the European ID Network for Improved Drug Efficacy and Availability, joins Helen Winsor from Pharma IQ, to discuss the u...
Spray-Dried Dispersion Technology: Solving Drug Solubility Challenges
March 09 by Amber ScorahAmorphous spray dried dispersions (SDDs) have emerged as a broadly applicable technology for the delivery of poorly soluble drug molecules. Methods for formulating and predicting the physical stabilit...
The Challenges of Amorphous Solid Dispersion Production: A Hoffman La Roche Perspective
July 11 by Pharma IQDr. Dave Miller, Senior Principal Scientist at Hoffmann La Roche, shares his views on how to optimise amorphous form selection, techniques to enhance amorphous drug performance and the best strategies...
Choosing the Best Techniques for Developing Amorphous Materials
June 13 by Pharma IQThe amorphous state is inherently instable. How do we keep amorphous forms from crystallising for as long as possible? Dr. Joseph Lubach from Genentech, joined Pharma IQ to discuss the challenges of p...